Transitioning from NAFLD to MAFLD to MASLD in the Mexican population B.A. Priego-Parra; R. Bernal-Reyes; M.E. Icaza-Chávez; S.E. Martínez-Vázquez; J.M. Remes-Troche;

Prevalence and clinical-epidemiologic characteristics of a Mexican population with metabolic (dysfunction) associated fatty liver disease: An open population study R. Bernal-Reyes; M.E. Icaza-Chávez; L.A. Chi-Cervera; J.M. Remes-Troche; M. Amieva-Balmori; B.A. Priego-Parra; S. Martínez-Vázquez; I.O. Méndez-Guerrero; L. Martínez-Rodríguez; A. Barranca-Enríquez; C. Palmeros-Exsome; A.D. Cano-Contreras; A. Triana-Romero;

Adjusted prevalence of metabolic-associated steatotic liver disease (MASLD) in a Mexican R. Bernal-Reyes R; B.A. Priego-Parra; M.E. Icaza-Chávez; J.M. Remes-Troche;